Related Experiment Videos
Inhibition of drug metabolism by fluoxetine
Research Communications in Chemical Pathology and Pharmacology
|February 1, 1976
Abstract:
Fluoxetine hydrochloride (Lilly 110140: 3-p-trifluoromethylphenoxy-3-phenyl-N-methyl-propylamine hydrochloride) inhibited the metabolism of hexobarbital and ethinamate in rodents and prolonged the hypnotic effects of these drugs.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HIV Pharmacist's Impact on Inpatient Antiretroviral Errors.
HIV medicine·2016
Current HIV treatment guidelines--an overview.
Current pharmaceutical design·2006
Management protocol for abacavir-related hypersensitivity reaction.
The Annals of pharmacotherapy·2000
Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.
The Journal of pharmacology and experimental therapeutics·1995
Hantavirus pulmonary syndrome: the Four Corners disease.
The Annals of pharmacotherapy·1995
Is heat acclimation able to increase whole-body sensitivity to insulin?
Research communications in chemical pathology and pharmacology·1994
Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.
Research communications in chemical pathology and pharmacology·1994
Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
Research communications in chemical pathology and pharmacology·1994
Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.
Research communications in chemical pathology and pharmacology·1994
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Research communications in chemical pathology and pharmacology·1994
Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Research communications in chemical pathology and pharmacology·1994
LRRC57/RABIN is a presynaptic inhibitor of Rab GTPases in glutamatergic neurons.
bioRxiv : the preprint server for biology·2026
A scoping review of adverse events associated with concomitant beta-adrenoreceptor blockers and selective serotonin reuptake inhibitors.
British journal of clinical pharmacology·2026
Optimal drug, dose and duration of antipsychotic therapy following amphetamine and cannabis-induced psychosis: A systematic review.
The Australian and New Zealand journal of psychiatry·2026
Effects of opioids and stimulants on the respiratory system.
European respiratory review : an official journal of the European Respiratory Society·2026